Translate
Ars Pharmaceuticals, Inc.
About
9.13USD+0.63 +7.41%
Closed • Updated at 18:09 GMT+00:00Market Cap$906.64M
Volume1.02M
Beta1.40
RSI61.52
Gross Margin74.12%
Ars Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 15 2026
ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update
May 13 2026
ARS Pharmaceuticals Strengthens Leadership Team with Appointment of Industry Veteran Donn Casale as President
May 7 2026
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
Apr 15 2026
neffy® (epinephrine nasal spray) Approved in Canada as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
Mar 27 2026
ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label
Recent Videos
ARS Pharmaceuticals Q1 2026 Earnings Call | neffy European Launch Set For Q3 As Revenue Beats
May 16, 2026
ARS Pharmaceuticals Stock Analysis | The 184% Growth Disconnect
May 15, 2026
2026 Mega Food Allergy Awareness Week Giveaway!
May 06, 2026
ARS Pharma's Neffy: Revolutionizing Allergy Treatment!
Apr 30, 2026
Community Chat
Ask AI
Try asking